Published in Psychiatr Clin North Am on April 10, 2012
Factors associated with willingness to take extended release naltrexone among injection drug users. Addict Sci Clin Pract (2015) 0.87
Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence. Subst Abus (2015) 0.78
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet (2011) 6.35
Opioid overdose deaths can occur in patients with naltrexone implants. Med J Aust (2007) 4.86
Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA (2005) 4.54
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2006) 3.06
Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry (2001) 2.29
Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants. Addict Biol (2004) 2.14
Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction (2004) 1.74
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat (2006) 1.63
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology (Berl) (2001) 1.53
How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Addict Med (2011) 1.49
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther (2004) 1.46
Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl) (2006) 1.44
Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Am J Psychiatry (2008) 1.42
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence. J Subst Abuse Treat (2000) 1.37
Behavioral naltrexone therapy: an integrated treatment for opiate dependence. J Subst Abuse Treat (2002) 1.36
Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants. Drug Alcohol Depend (2005) 1.33
Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain (2000) 1.31
Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment. Exp Clin Psychopharmacol (2007) 1.29
Naltrexone and buprenorphine combination in the treatment of opioid dependence. J Psychopharmacol (2006) 1.21
Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available. Curr Psychiatry Rep (2010) 1.16
Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology (1997) 1.10
Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants. Addict Biol (2004) 1.06
Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders. Clin Pharmacol Ther (2008) 1.03
Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. J Pain (2008) 1.01
Lofexidine versus clonidine in rapid opiate detoxification. J Subst Abuse Treat (2001) 0.95
Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex. J Pain (2005) 0.91
Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. Drug Alcohol Depend (2011) 0.90
Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone. Addiction (2008) 0.89
A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal. Drug Alcohol Depend (2008) 0.88
A comparison of oral and implant naltrexone outcomes at 12 months. J Opioid Manag (2007) 0.86
Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence. Addict Biol (2003) 0.86
Plasma concentrations during naltrexone implant treatment of opiate-dependent patients. Br J Clin Pharmacol (2004) 0.84
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone. Psychopharmacology (Berl) (2010) 0.83
Pharmacological enhancement of naltrexone treatment for opioid dependence: a review. Subst Abuse Rehabil (2011) 0.83
A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts. Addiction (1998) 0.79
Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients. Life Sci (2005) 0.77
The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health. Am J Psychiatry (2009) 4.10
The methamphetamine problem in the United States. Annu Rev Public Health (2010) 2.00
Psychiatric symptoms and substance use disorders in a nationally representative sample of American adolescents involved with foster care. J Adolesc Health (2006) 1.91
The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction. Subst Abuse Rehabil (2012) 1.44
The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health. Am J Geriatr Psychiatry (2009) 1.31
Inhalant use among incarcerated adolescents in the United States: prevalence, characteristics, and correlates of use. Drug Alcohol Depend (2007) 1.27
Screening for alcohol and drug use disorders among adults in primary care: a review. Subst Abuse Rehabil (2012) 1.26
Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev (2011) 1.15
Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav (2013) 1.14
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials (2008) 1.14
Nonprescription use of pain relievers by middle-aged and elderly community-living adults: National Survey on Drug Use and Health. J Am Geriatr Soc (2009) 1.09
Substance abuse, treatment needs and access among female sex workers and non-sex workers in Pretoria, South Africa. Subst Abuse Treat Prev Policy (2009) 1.07
The epidemiology of alcohol use disorders and subthreshold dependence in a middle-aged and elderly community sample. Am J Geriatr Psychiatry (2011) 1.06
Integrating substance abuse care with community diabetes care: implications for research and clinical practice. Subst Abuse Rehabil (2013) 1.04
Alcohol limits in older people. Addiction (2012) 1.02
Substance abuse among individuals with intellectual disabilities. Res Dev Disabil (2012) 0.99
Patterns of tobacco use and tobacco-related psychiatric morbidity and substance use among middle-aged and older adults in the United States. Aging Ment Health (2012) 0.99
Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network. Am J Drug Alcohol Abuse (2011) 0.97
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. Addict Biol (2008) 0.96
Eight weeks of exercise training improves fitness measures in methamphetamine-dependent individuals in residential treatment. J Addict Med (2013) 0.96
Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network. Subst Use Misuse (2011) 0.95
Comparing buprenorphine induction experience with heroin and prescription opioid users. J Subst Abuse Treat (2012) 0.93
Cocaine use and the occurrence of panic attacks in the community: a case-crossover approach. Subst Use Misuse (2005) 0.91
Postpartum substance use and depressive symptoms: a review. Women Health (2013) 0.91
Prescription and over-the-counter drug treatment admissions to the California public treatment system. J Subst Abuse Treat (2010) 0.90
Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials Network. Subst Abuse Rehabil (2011) 0.90
Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction (2014) 0.89
Substance Use among Adolescent Mothers: A Review. Child Youth Serv Rev (2013) 0.87
Exercise training improves heart rate variability after methamphetamine dependency. Med Sci Sports Exerc (2014) 0.85
Pharmacological enhancement of naltrexone treatment for opioid dependence: a review. Subst Abuse Rehabil (2011) 0.83
Association Between Substance Use and Gun-Related Behaviors. Epidemiol Rev (2016) 0.82
Use of Salvia divinorum in a nationally representative sample. Am J Drug Alcohol Abuse (2011) 0.82
Trends and Correlates of Cannabis-involved Emergency Department Visits: 2004 to 2011. J Addict Med (2016) 0.81
Associations between cigarette smoking and pain among veterans. Epidemiol Rev (2015) 0.81
The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample. Am J Addict (2013) 0.80
Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence. Am J Psychiatry (2011) 0.80
Early outcomes following low dose naltrexone enhancement of opioid detoxification. Am J Addict (2009) 0.80
Correlates of handgun carrying among adolescents in the United States. J Interpers Violence (2012) 0.80
Risk profiles among adolescent nonmedical opioid users in the United States. Addict Behav (2012) 0.79
Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives. Curr Drug Abuse Rev (2012) 0.79
Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. Subst Abuse Treat Prev Policy (2012) 0.79
The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample. Subst Abuse Rehabil (2011) 0.79
Trends in nonheroin opioid abuse admissions: 1992-2004. J Opioid Manag (2007) 0.79
Smoking and opioid detoxification: behavioral changes and response to treatment. Nicotine Tob Res (2013) 0.78
Reduced cannabis use after low-dose naltrexone addition to opioid detoxification. J Clin Psychopharmacol (2010) 0.78
Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three models. BMC Public Health (2013) 0.77
Hepatitis A and B infection among methamphetamine-dependent users. J Subst Abuse Treat (2008) 0.77
Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence. J Clin Psychopharmacol (2007) 0.77
Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence. J Psychiatr Res (2008) 0.76
Problem drinking and low-dose naltrexone-assisted opioid detoxification. J Stud Alcohol Drugs (2011) 0.76
Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention. Am J Addict (2014) 0.76
The national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directions. Clin Trials (2013) 0.75
Food, class, and health: the role of the perceived body in the social reproduction of health. Health Commun (2012) 0.75
The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal. Am J Drug Alcohol Abuse (2012) 0.75
Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention. Am J Addict (2015) 0.75
Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States. J Addict Med (2017) 0.75
The Association of Gasoline Prices With Hospital Utilization and Costs for Motorcycle and Nonmotorcycle Motor Vehicle Injuries in the United States. Med Care (2016) 0.75